[
    [
        {
            "time": "2018-08-30",
            "original_text": "复星医药：重庆食药监局已就信件内容进行飞行检查 结果尚待结论性意见",
            "features": {
                "keywords": [
                    "复星医药",
                    "飞行检查",
                    "重庆食药监局"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药：重庆食药监局已就信件内容进行飞行检查 结果尚待结论性意见",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-30",
            "original_text": "复星医药遭员工举报：比长生生物更恶劣 多次遭美国FDA警告 诉讼纠纷",
            "features": {
                "keywords": [
                    "复星医药",
                    "员工举报",
                    "长生生物",
                    "FDA警告",
                    "诉讼纠纷"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药遭员工举报：比长生生物更恶劣 多次遭美国FDA警告 诉讼纠纷",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-08-30",
            "original_text": "又一个长生生物？复星医药旗下公司遭员工举报",
            "features": {
                "keywords": [
                    "复星医药",
                    "长生生物",
                    "员工举报"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "又一个长生生物？复星医药旗下公司遭员工举报",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-30",
            "original_text": "复星医药子公司被举报生产和检验记录造假，重庆检查组已入驻 诉讼纠纷",
            "features": {
                "keywords": [
                    "复星医药",
                    "子公司",
                    "记录造假",
                    "重庆检查组",
                    "诉讼纠纷"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药子公司被举报生产和检验记录造假，重庆检查组已入驻 诉讼纠纷",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-08-30",
            "original_text": "复星医药回应子公司被举报编造生产记录、骗取GMP证书：不符合事实",
            "features": {
                "keywords": [
                    "复星医药",
                    "子公司",
                    "生产记录",
                    "GMP证书",
                    "回应"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药回应子公司被举报编造生产记录、骗取GMP证书：不符合事实",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-30",
            "original_text": "医药行业交9年来最好成绩单 研发投入加码",
            "features": {
                "keywords": [
                    "医药行业",
                    "研发投入",
                    "成绩单"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业交9年来最好成绩单 研发投入加码",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-08-30",
            "original_text": "郭广昌：经济下行有更多投资机会 复星净负债率将控制在60%以下",
            "features": {
                "keywords": [
                    "郭广昌",
                    "经济下行",
                    "投资机会",
                    "净负债率"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "郭广昌：经济下行有更多投资机会 复星净负债率将控制在60%以下",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-30",
            "original_text": "复星国际上半年净利同比增长17% 郭广昌：继续推动核心资产对接资本市场",
            "features": {
                "keywords": [
                    "复星国际",
                    "净利增长",
                    "郭广昌",
                    "核心资产",
                    "资本市场"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星国际上半年净利同比增长17% 郭广昌：继续推动核心资产对接资本市场",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-08-30",
            "original_text": "医药行业周报: 国家药监局就药品信息化追溯体系建设征求意见",
            "features": {
                "keywords": [
                    "医药行业",
                    "国家药监局",
                    "药品追溯体系",
                    "征求意见"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报: 国家药监局就药品信息化追溯体系建设征求意见",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        }
    ]
]